Filing Details
- Accession Number:
- 0001209191-10-056700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-23 21:58:31
- Reporting Period:
- 2010-11-19
- Filing Date:
- 2010-11-23
- Accepted Time:
- 2010-11-23 21:58:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
876343 | Biotime Inc | BTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1054745 | Judith Segall | 1301 Harbor Bay Parkway Alameda CA 94502 | Vice President & Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Disposition | 2010-11-19 | 7,600 | $7.47 | 539,943 | No | 4 | S | Direct | |
Common Shares, No Par Value | Disposition | 2010-11-22 | 17,400 | $7.52 | 522,543 | No | 4 | S | Direct | |
Common Shares, No Par Value | Disposition | 2010-11-23 | 2,128 | $7.70 | 520,415 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Option to Purchase Common Shares | $0.32 | 2006-11-24 | 2011-11-23 | 80,000 | 80,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2011-11-23 | 80,000 | 80,000 | Direct |
Footnotes
- The price of $7.4730 per share represents a weighted average of sales prices ranging from $7.45 to $7.4950 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Includes 23,750 shares acquired through a warrant exercise at $1.818 per share on August 18, 2010; 21,586 shares acquired through a warrant exercise at $2.00 per share on November 1, 2010; and 125,000 shares acquired through an option exercise at $2.00 per share on November 5, 2010. Does not include shares that may be acquired upon the exercise of certain stock options.
- The price of $7.5223 per share represents a weighted average of sales prices ranging from $7.4592 to $7.57 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $7.6976 per share represents a weighted average of sales prices ranging from $7.68 to $7.72 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.